Correlation Between Guggenheim Diversified and Franklin Biotechnology

Can any of the company-specific risk be diversified away by investing in both Guggenheim Diversified and Franklin Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Guggenheim Diversified and Franklin Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Guggenheim Diversified Income and Franklin Biotechnology Discovery, you can compare the effects of market volatilities on Guggenheim Diversified and Franklin Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Guggenheim Diversified with a short position of Franklin Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Guggenheim Diversified and Franklin Biotechnology.

Diversification Opportunities for Guggenheim Diversified and Franklin Biotechnology

0.0

Correlation Coefficient

Guggenheim Diversified  Franklin Biotechnology

Pay attention - limited upside

The 3 months correlation between Guggenheim and Franklin is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Guggenheim Diversified Income and Franklin Biotechnology Discove in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Biotechnology and Guggenheim Diversified is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Guggenheim Diversified Income are associated (or correlated) with Franklin Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Biotechnology has no effect on the direction of Guggenheim Diversified i.e., Guggenheim Diversified and Franklin Biotechnology go up and down completely randomly.

Pair Corralation between Guggenheim Diversified and Franklin Biotechnology

If you would invest  2,543  in Guggenheim Diversified Income on October 7, 2024 and sell it today you would earn a total of  0.00  from holding Guggenheim Diversified Income or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Guggenheim Diversified Income  vs.  Franklin Biotechnology Discove

Guggenheim Diversified

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Guggenheim Diversified Income has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Guggenheim Diversified is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Franklin Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Franklin Biotechnology Discovery has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Pair Trading with Guggenheim Diversified and Franklin Biotechnology

The main advantage of trading using opposite Guggenheim Diversified and Franklin Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Guggenheim Diversified position performs unexpectedly, Franklin Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Biotechnology will offset losses from the drop in Franklin Biotechnology's long position.

The idea behind Guggenheim Diversified Income and Franklin Biotechnology Discovery pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.